ArticleFrontiers in cardiovascular medicine2026
Takotsubo cardiomyopathy concurrent with hyperthyroidism following COVID-19-a case report and literature review.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The convergence of viral infection, autoimmune thyroid disease, and cardiovascular vulnerability may create a "triple systemic stress" predisposing to Takotsubo cardiomyopathy (TTS). We describe a case illustrating this potential pathophysiological triad. Case presentation: A previously healthy 21-year-old male presented with sinus tachycardia, anterior ST-segment elevation on preoperative Electrocardiogram (ECG), and regional wall motion abnormalities on echocardiography two weeks after SARS-CoV-2 infection. Emergency coronary angiography ruled out myocardial infarction and coronary stenosis. Clinical features suggested thyrotoxicosis, confirmed by biochemical and imaging studies. Cardiac magnetic resonance demonstrates subendocardial hypoperfusion in the interventricular septum accompanied by abnormal myocardial motion. Treatment with methimazole and beta-blockers led to resolution of cardiac dysfunction and gradual normalization of thyroid function. Conclusion: This case report describes a temporal association among SARS-CoV-2 infection, exacerbation of autoimmune thyroid dysfunction, and Takotsubo syndrome. The virus may contribute to Graves' disease exacerbation through immune-inflammatory mechanisms, while potentially inducing myocardial stress via cytokine-mediated pathways. These converging factors-combined with thyrotoxicosis-related catecholamine sensitivity-may act synergistically to increase TTS susceptibility. Clinically, thyroid evaluation may be considered in COVID-19 patients presenting with cardiac symptoms, and an integrated management approach addressing viral, endocrine, and cardiovascular aspects could be beneficial. The precise interconnections among these factors remain speculative and warrant further investigation in larger cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.